Esophagus Cancer Completed Phase 2 Trials for Docetaxel (DB01248)

IndicationStatusPhase
DBCOND0032126 (Esophagus Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00318903Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal CancerTreatment